Cencora, Inc. $COR Stock Acquired by Kestra Advisory Services LLC

Kestra Advisory Services LLC increased its position in Cencora, Inc. (NYSE:COR) by 86.0% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 16,691 shares of the company’s stock after acquiring an additional 7,716 shares during the period. Kestra Advisory Services LLC’s holdings in Cencora were worth $5,012,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Pinnacle Associates Ltd. lifted its holdings in shares of Cencora by 1.8% during the third quarter. Pinnacle Associates Ltd. now owns 2,203 shares of the company’s stock valued at $662,000 after purchasing an additional 38 shares in the last quarter. Elmwood Wealth Management Inc. boosted its position in shares of Cencora by 0.9% during the second quarter. Elmwood Wealth Management Inc. now owns 4,314 shares of the company’s stock valued at $1,221,000 after buying an additional 40 shares during the last quarter. Signature Equity Partners LLC increased its holdings in Cencora by 4.6% in the 1st quarter. Signature Equity Partners LLC now owns 937 shares of the company’s stock worth $294,000 after buying an additional 41 shares in the last quarter. Mosley Wealth Management increased its holdings in Cencora by 11.5% in the 3rd quarter. Mosley Wealth Management now owns 407 shares of the company’s stock worth $122,000 after buying an additional 42 shares in the last quarter. Finally, Weaver Consulting Group increased its holdings in Cencora by 2.5% in the 3rd quarter. Weaver Consulting Group now owns 1,798 shares of the company’s stock worth $540,000 after buying an additional 44 shares in the last quarter. 97.52% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have issued reports on COR shares. Evercore restated an “outperform” rating and set a $350.00 target price (up from $330.00) on shares of Cencora in a research note on Thursday, August 6th. Robert W. Baird lifted their price target on shares of Cencora from $373.00 to $375.00 and gave the stock an “outperform” rating in a research note on Thursday, October 22nd. Morgan Stanley lifted their price target on shares of Cencora from $346.00 to $377.00 and gave the stock an “overweight” rating in a research note on Friday, October 30th. Wall Street Zen raised shares of Cencora from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Finally, Wells Fargo & Company increased their price objective on shares of Cencora from $331.00 to $395.00 and gave the company an “overweight” rating in a research report on Tuesday, August 11th. Twelve equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $368.14.

Insider Transactions at Cencora

In other Cencora news, EVP Elizabeth Campbell sold 11,300 shares of the stock in a transaction on Monday, August 24th. The shares were sold at an average price of $324.12, for a total transaction of $3,662,556.00. Following the completion of the transaction, the executive vice president owned 19,455 shares in the company, valued at $6,305,754.60. This trade represents a 36.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.38% of the stock is currently owned by insiders.

Cencora Price Performance

Shares of NYSE:COR opened at $349.32 on Friday. The firm has a market cap of $66.66 billion, a price-to-earnings ratio of 19.47, a P/E/G ratio of 1.81 and a beta of 0.58. The firm has a fifty day moving average price of $326.68 and a 200 day moving average price of $317.19. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The company has a debt-to-equity ratio of 3.01, a quick ratio of 0.59 and a current ratio of 0.94.

Cencora (NYSE:COR) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $4.66 EPS for the quarter, topping the consensus estimate of $4.58 by $0.08. The business had revenue of $88.35 billion for the quarter, compared to analysts’ expectations of $87.95 billion. Cencora had a net margin of 1.03% and a return on equity of 110.72%. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.84 EPS. As a group, sell-side analysts expect that Cencora, Inc. will post 19.58 earnings per share for the current fiscal year.

Cencora Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, November 13th. This is a positive change from Cencora’s previous quarterly dividend of $0.60. This represents a $2.64 dividend on an annualized basis and a yield of 0.8%. Cencora’s payout ratio is currently 13.39%.

Cencora Company Profile

Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical services company that connects pharmaceutical manufacturers with healthcare providers. Its core business includes sourcing and distributing medicines and other healthcare products to pharmacies, hospitals, health systems and other care providers. The company also provides services supporting specialty pharmaceuticals, including logistics, consulting and solutions for manufacturers and healthcare organizations. These services help manage the handling and delivery of complex medicines and support access to treatments.